Abstract
Objective: The purpose of this study was to examine the effects of oral glucosamine supplementation on the functional ability and degree of pain felt by individuals who had regular knee pain, most likely due to previous articular cartilage damage, and possibly osteoarthritis.
Methods: Subjects were randomly supplemented with either glucosamine (G) (n=24) or placebo (P) (lactose) (n=22) for 12 weeks at a dose of 2000 mg per day. Over this period, four testing sessions were conducted, with changes in knee pain and function assessed by clinical and functional tests, (joint line palpation, a 3 metre "duck walk" and a repeated, walking stair climb), two questionnaires (the Knee Injury and Osteoarthritis Outcome Score (KOOS) and the Knee Pain Scale (KPS)) and participant subjective evaluations.
Results: The clinical and functional test scores improved with time (main effects: p<0.05, p<0.01) but there were no significant differences between the two groups. The questionnaire results also recorded a significant main effect for time (p<0.05), but the glucosamine group was found to have significantly better KOOS quality of life scores at week eight and 12 (p<0.05), and lower KPS scores (p<0.05) at week eight than the placebo group. On self report evaluations of changes across the 12 week supplementation period, 88% (n=21) of the glucosamine group reported some degree of improvement in their knee pain versus only 17% (n=3) in the placebo group.
Conclusions: These results suggest that glucosamine supplementation can provide some degree of pain relief and improved function in persons who experience regular knee pain, which may be caused by prior cartilage injury and/or osteoarthritis. The trends in the results also suggest that, at a dosage of 2000 mg per day, the majority of improvements are present after eight weeks.
Full Text
The Full Text of this article is available as a PDF (103.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barclay T. S., Tsourounis C., McCart G. M. Glucosamine. Ann Pharmacother. 1998 May;32(5):574–579. doi: 10.1345/aph.17235. [DOI] [PubMed] [Google Scholar]
- Cerrato P. L. Can these compounds curb arthritis? RN. 1998 Apr;61(4):57–58. [PubMed] [Google Scholar]
- Crolle G., D'Este E. Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr Med Res Opin. 1980;7(2):104–109. doi: 10.1185/03007998009112035. [DOI] [PubMed] [Google Scholar]
- D'Ambrosio E., Casa B., Bompani R., Scali G., Scali M. Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmatherapeutica. 1981;2(8):504–508. [PubMed] [Google Scholar]
- Davis M. A., Ettinger W. H., Neuhaus J. M., Mallon K. P. Knee osteoarthritis and physical functioning: evidence from the NHANES I Epidemiologic Followup Study. J Rheumatol. 1991 Apr;18(4):591–598. [PubMed] [Google Scholar]
- Drovanti A., Bignamini A. A., Rovati A. L. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clin Ther. 1980;3(4):260–272. [PubMed] [Google Scholar]
- Lopes Vaz A. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. Curr Med Res Opin. 1982;8(3):145–149. doi: 10.1185/03007998209112375. [DOI] [PubMed] [Google Scholar]
- McCarty M. F. Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis. Med Hypotheses. 1998 Jun;50(6):507–510. doi: 10.1016/s0306-9877(98)90272-9. [DOI] [PubMed] [Google Scholar]
- McCarty M. F. Glucosamine for wound healing. Med Hypotheses. 1996 Oct;47(4):273–275. doi: 10.1016/s0306-9877(96)90066-3. [DOI] [PubMed] [Google Scholar]
- McCarty M. F. The neglect of glucosamine as a treatment for osteoarthritis--a personal perspective. Med Hypotheses. 1994 May;42(5):323–327. doi: 10.1016/0306-9877(94)90007-8. [DOI] [PubMed] [Google Scholar]
- Pujalte J. M., Llavore E. P., Ylescupidez F. R. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med Res Opin. 1980;7(2):110–114. doi: 10.1185/03007998009112036. [DOI] [PubMed] [Google Scholar]
- Reichelt A., Förster K. K., Fischer M., Rovati L. C., Setnikar I. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study. Arzneimittelforschung. 1994 Jan;44(1):75–80. [PubMed] [Google Scholar]
- Rejeski W. J., Ettinger W. H., Jr, Shumaker S., Heuser M. D., James P., Monu J., Burns R. The evaluation of pain in patients with knee osteoarthritis: the knee pain scale. J Rheumatol. 1995 Jun;22(6):1124–1129. [PubMed] [Google Scholar]
- Rindone J. P., Hiller D., Collacott E., Nordhaugen N., Arriola G. Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West J Med. 2000 Feb;172(2):91–94. doi: 10.1136/ewjm.172.2.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roos E. M., Roos H. P., Lohmander L. S., Ekdahl C., Beynnon B. D. Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998 Aug;28(2):88–96. doi: 10.2519/jospt.1998.28.2.88. [DOI] [PubMed] [Google Scholar]
- Rovati L. C. Clinical research in osteoarthritis: design and results of short-term and long-term trials with disease-modifying drugs. Int J Tissue React. 1992;14(5):243–251. [PubMed] [Google Scholar]
- Vidal y Plana R. R., Bizzarri D., Rovati A. L. Articular cartilage pharmacology: I. In vitro studies on glucosamine and non steroidal antiinflammatory drugs. Pharmacol Res Commun. 1978 Jun;10(6):557–569. doi: 10.1016/s0031-6989(78)80054-x. [DOI] [PubMed] [Google Scholar]
- da Camara C. C., Dowless G. V. Glucosamine sulfate for osteoarthritis. Ann Pharmacother. 1998 May;32(5):580–587. doi: 10.1345/aph.17214. [DOI] [PubMed] [Google Scholar]